{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:45:09Z","timestamp":1791776709610,"version":"4.3.4"},"reference-count":90,"publisher":"IMR Press","issue":"7","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30872716"],"award-info":[{"award-number":["30872716"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"crossref","award":["2015CFB288"],"award-info":[{"award-number":["2015CFB288"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Open Foundation of Hubei Province Key Laboratory of Tumor Microenvironment and immunotherapy","award":["2023KZL06"],"award-info":[{"award-number":["2023KZL06"]}]},{"name":"Open Foundation of Hubei Province Key Laboratory of Tumor Microenvironment and immunotherapy","award":["2024KZL03"],"award-info":[{"award-number":["2024KZL03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Cardiovascular disease (CVD) remains the leading cause of death worldwide, highlighting the urgent need to identify effective therapeutic targets. Ankyrin repeat domain 1 (ANKRD1), also known as cardiac ankyrin repeat protein (CARP), is a member of the muscle ankyrin repeat protein (MARP) family. The unique multi-domain cooperative mechanism and dynamic nucleocytoplasmic shuttling associated with ANKRD1 confer increasingly significant roles in the pathogenesis and progression of CVD. This review aims to summarize the current understanding of the molecular structure of ANKRD1, elucidate the mechanisms underlying key cardiovascular pathological processes, including myocardial remodeling, cardiomyopathy, cardiac development, myocardial infarction, and heart failure, and comprehensively evaluate its potential as a therapeutic target. Furthermore, this review aims to provide new theoretical foundations and future research directions for the precision diagnosis and treatment of CVD.<\/jats:p>","DOI":"10.31083\/rcm48749","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:31:43Z","timestamp":1785407503000},"source":"Crossref","is-referenced-by-count":1,"title":["Ankyrin Repeat Domain 1: A Key Regulatory Factor and Emerging Therapeutic Target in Heart Disease"],"prefix":"10.31083","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0433-3973","authenticated-orcid":true,"given":"Ziyuan","family":"Wang","sequence":"first","affiliation":[{"name":"Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, 443002 Yichang, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yiling People\u2019s Hospital of Yichang, 443002 Yichang, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5089-2412","authenticated-orcid":true,"given":"Shizhong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, 443002 Yichang, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovascular Diabetology. 2022; 21: 68.","DOI":"10.1186\/s12933-022-01511-x"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Hemmati M, Kashanipoor S, Mazaheri P, Alibabaei F, Babaeizad A, Asli S, et al. Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD). Life Sciences. 2023; 329: 121947.","DOI":"10.1016\/j.lfs.2023.121947"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016; 133: e38\u2013360.","DOI":"10.1161\/CIR.0000000000000350"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Zhang N, Ye F, Zhou Y, Zhu W, Xie C, Zheng H, et al. Cardiac ankyrin repeat protein contributes to dilated cardiomyopathy and heart failure. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. 2021; 35: e21488.","DOI":"10.1096\/fj.201902802RR"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Miller MK, Bang ML, Witt CC, Labeit D, Trombitas C, Watanabe K, et al. The muscle ankyrin repeat proteins: CARP, ankrd2\/Arpp and DARP as a family of titin filament-based stress response molecules. Journal of Molecular Biology. 2003; 333: 951\u2013964.","DOI":"10.1016\/j.jmb.2003.09.012"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Chu W, Burns DK, Swerlick RA, Presky DH. Identification and characterization of a novel cytokine-inducible nuclear protein from human endothelial cells. The Journal of Biological Chemistry. 1995; 270: 10236\u201310245.","DOI":"10.1074\/jbc.270.17.10236"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Jeyaseelan R, Poizat C, Baker RK, Abdishoo S, Isterabadi LB, Lyons GE, et al. A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. The Journal of Biological Chemistry. 1997; 272: 22800\u201322808.","DOI":"10.1074\/jbc.272.36.22800"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Zou Y, Evans S, Chen J, Kuo HC, Harvey RP, Chien KR. CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway. Development (Cambridge, England). 1997; 124: 793\u2013804.","DOI":"10.1242\/dev.124.4.793"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Kojic S, Radojkovic D, Faulkner G. Muscle ankyrin repeat proteins: their role in striated muscle function in health and disease. Critical Reviews in Clinical Laboratory Sciences. 2011; 48: 269\u2013294.","DOI":"10.3109\/10408363.2011.643857"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Zhang B, Peng ZY. A minimum folding unit in the ankyrin repeat protein p16(INK4). Journal of Molecular Biology. 2000; 299: 1121\u20131132.","DOI":"10.1006\/jmbi.2000.3803"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Mosavi LK, Cammett TJ, Desrosiers DC, Peng ZY. The ankyrin repeat as molecular architecture for protein recognition. Protein Science : a Publication of the Protein Society. 2004; 13: 1435\u20131448.","DOI":"10.1110\/ps.03554604"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Gorina S, Pavletich NP. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science (New York, N.Y.). 1996; 274: 1001\u20131005.","DOI":"10.1126\/science.274.5289.1001"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Laure L, Dani\u00e8le N, Suel L, Marchand S, Aubert S, Bourg N, et al. A new pathway encompassing calpain 3 and its newly identified substrate cardiac ankyrin repeat protein is involved in the regulation of the nuclear factor-\u03baB pathway in skeletal muscle. The FEBS Journal. 2010; 277: 4322\u20134337.","DOI":"10.1111\/j.1742-4658.2010.07820.x"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Gronostajski RM, Goldberg AL, Pardee AB. Energy requirement for degradation of tumor-associated protein p53. Molecular and Cellular Biology. 1984; 4: 442\u2013448.","DOI":"10.1128\/mcb.4.3.442-448.1984"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Rogers S, Wells R, Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science (New York, N.Y.). 1986; 234: 364\u2013368.","DOI":"10.1126\/science.2876518"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Dhyani A, Duarte ASS, Machado-Neto JA, Favaro P, Ortega MM, Olalla Saad ST. ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells. FEBS Letters. 2012; 586: 4311\u20134318.","DOI":"10.1016\/j.febslet.2012.10.037"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Dhyani A, Machado-Neto JA, Favaro P, Saad STO. ANKHD1 represses p21 (WAF1\/CIP1) promoter and promotes multiple myeloma cell growth. European Journal of Cancer (Oxford, England : 1990). 2015; 51: 252\u2013259.","DOI":"10.1016\/j.ejca.2014.11.012"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Ling SSM, Chen YT, Wang J, Richards AM, Liew OW. Ankyrin Repeat Domain 1 Protein: A Functionally Pleiotropic Protein with Cardiac Biomarker Potential. International Journal of Molecular Sciences. 2017; 18: 1362.","DOI":"10.3390\/ijms18071362"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Lun AS, Chen J, Lange S. Probing muscle ankyrin-repeat protein (MARP) structure and function. Anatomical Record (Hoboken, N.J. : 2007). 2014; 297: 1615\u20131629.","DOI":"10.1002\/ar.22968"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Demetriadou A, Morales-Sanfrutos J, Nearchou M, Baba O, Kyriacou K, Tate EW, et al. Mouse Stbd1 is N-myristoylated and affects ER-mitochondria association and mitochondrial morphology. Journal of Cell Science. 2017; 130: 903\u2013915.","DOI":"10.1242\/jcs.195263"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Santonico E, Belleudi F, Panni S, Torrisi MR, Cesareni G, Castagnoli L. Multiple modification and protein interaction signals drive the Ring finger protein 11 (RNF11) E3 ligase to the endosomal compartment. Oncogene. 2010; 29: 5604\u20135618.","DOI":"10.1038\/onc.2010.294"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Merkler DJ, Hawley AJ, Eipper BA, Mains RE. Peptidylglycine \u03b1-amidating monooxygenase as a therapeutic target or biomarker for human diseases. British Journal of Pharmacology. 2022; 179: 3306\u20133324.","DOI":"10.1111\/bph.15815"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Lin Y, Lubman DM. The role of N-glycosylation in cancer. Acta Pharmaceutica Sinica. B. 2024; 14: 1098\u20131110.","DOI":"10.1016\/j.apsb.2023.10.014"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Mullenger JL, Zeidler MP, Fragiadaki M. Evaluating the Molecular Properties and Function of ANKHD1, and Its Role in Cancer. International Journal of Molecular Sciences. 2023; 24: 12834.","DOI":"10.3390\/ijms241612834"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Research. 2015; 43: D512\u2013D520.","DOI":"10.1093\/nar\/gku1267"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, et al. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Research. 2025; 53: D1670\u2013D1676.","DOI":"10.1093\/nar\/gkae973"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Samaras SE, Shi Y, Davidson JM. CARP: fishing for novel mechanisms of neovascularization. The Journal of Investigative Dermatology. Symposium Proceedings. 2006; 11: 124\u2013131.","DOI":"10.1038\/sj.jidsymp.5650014"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Baumeister A, Arber S, Caroni P. Accumulation of muscle ankyrin repeat protein transcript reveals local activation of primary myotube endcompartments during muscle morphogenesis. The Journal of Cell Biology. 1997; 139: 1231\u20131242.","DOI":"10.1083\/jcb.139.5.1231"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Shi Y, Reitmaier B, Regenbogen J, Slowey RM, Opalenik SR, Wolf E, et al. CARP, a cardiac ankyrin repeat protein, is up-regulated during wound healing and induces angiogenesis in experimental granulation tissue. The American Journal of Pathology. 2005; 166: 303\u2013312.","DOI":"10.1016\/S0002-9440(10)62254-7"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Samaras SE, Chen B, Koch SR, Sawyer DB, Lim CC, Davidson JM. 26S proteasome regulation of Ankrd1\/CARP in adult rat ventricular myocytes and human microvascular endothelial cells. Biochemical and Biophysical Research Communications. 2012; 425: 830\u2013835.","DOI":"10.1016\/j.bbrc.2012.07.162"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Frangogiannis NG. Cardiac fibrosis. Cardiovascular Research. 2021; 117: 1450\u20131488.","DOI":"10.1093\/cvr\/cvaa324"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Bibi A, Bartekova M, Gandhi S, Greco S, Mad\u00e8 A, Sarkar M, et al. Circular RNA regulatory role in pathological cardiac remodelling. British Journal of Pharmacology. 2025; 182: 316\u2013339.","DOI":"10.1111\/bph.16434"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Piek A, de Boer RA, Sillj\u00e9 HHW. The fibrosis-cell death axis in heart failure. Heart Failure Reviews. 2016; 21: 199\u2013211.","DOI":"10.1007\/s10741-016-9536-9"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Wu QQ, Xiao Y, Yuan Y, Ma ZG, Liao HH, Liu C, et al. Mechanisms contributing to cardiac remodelling. Clinical Science (London, England : 1979). 2017; 131: 2319\u20132345.","DOI":"10.1042\/CS20171167"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Aihara Y, Kurabayashi M, Saito Y, Ohyama Y, Tanaka T, Takeda S, et al. Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter. Hypertension (Dallas, Tex. : 1979). 2000; 36: 48\u201353.","DOI":"10.1161\/01.hyp.36.1.48"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Chen C, Shen L, Cao S, Li X, Xuan W, Zhang J, et al. Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation. PloS One. 2014; 9: e104040.","DOI":"10.1371\/journal.pone.0104040"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Zhong L, Chiusa M, Cadar AG, Lin A, Samaras S, Davidson JM, et al. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy. Cardiovascular Research. 2015; 106: 261\u2013271.","DOI":"10.1093\/cvr\/cvv108"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Xie R, Yuan S, Hu G, Zhan J, Jin K, Tang Y, et al. Nuclear AGO2 promotes myocardial remodeling by activating ANKRD1 transcription in failing hearts. Molecular Therapy : the Journal of the American Society of Gene Therapy. 2024; 32: 1578\u20131594.","DOI":"10.1016\/j.ymthe.2024.03.018"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Rink\u016bnait\u0117 I, \u0160imoli\u016bnas E, Alksn\u0117 M, Bartkut\u0117 G, Labeit S, Bukelskien\u0117 V, et al. Genetic Ablation of Ankrd1 Mitigates Cardiac Damage during Experimental Autoimmune Myocarditis in Mice. Biomolecules. 2022; 12: 1898.","DOI":"10.3390\/biom12121898"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Meng H, Du Z, Lu W, Wang Q, Sun X, Jiang Y, et al. Baoyuan decoction (BYD) attenuates cardiac hypertrophy through ANKRD1-ERK\/GATA4 pathway in heart failure after acute myocardial infarction. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 2021; 89: 153617.","DOI":"10.1016\/j.phymed.2021.153617"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Song Y, Xu J, Li Y, Jia C, Ma X, Zhang L, et al. Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1\/2 and TGF-\u03b2 signaling pathways. PloS One. 2012; 7: e50436.","DOI":"10.1371\/journal.pone.0050436"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Chen B, Zhong L, Roush SF, Pentassuglia L, Peng X, Samaras S, et al. Disruption of a GATA4\/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy. PloS One. 2012; 7: e35743.","DOI":"10.1371\/journal.pone.0035743"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Kanai H, Tanaka T, Aihara Y, Takeda S, Kawabata M, Miyazono K, et al. Transforming growth factor-beta\/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells. Circulation Research. 2001; 88: 30\u201336.","DOI":"10.1161\/01.res.88.1.30"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Zhang N, Ye F, Zhu W, Hu D, Xiao C, Nan J, et al. Cardiac ankyrin repeat protein attenuates cardiomyocyte apoptosis by upregulation of Bcl-2 expression. Biochimica et Biophysica Acta. 2016; 1863: 3040\u20133049.","DOI":"10.1016\/j.bbamcr.2016.09.024"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Liu XH, Bauman WA, Cardozo C. ANKRD1 modulates inflammatory responses in C2C12 myoblasts through feedback inhibition of NF-\u03baB signaling activity. Biochemical and Biophysical Research Communications. 2015; 464: 208\u2013213.","DOI":"10.1016\/j.bbrc.2015.06.118"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"McNally EM, Mestroni L. Dilated Cardiomyopathy: Genetic Determinants and Mechanisms. Circulation Research. 2017; 121: 731\u2013748.","DOI":"10.1161\/CIRCRESAHA.116.309396"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Heymans S, Lakdawala NK, Tsch\u00f6pe C, Klingel K. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches. Lancet (London, England). 2023; 402: 998\u20131011.","DOI":"10.1016\/S0140-6736(23)01241-2"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Xu S, Zeng Y, Tan X, Zhang G, Xu A, Fan H, et al. Targeted Delivery of Exosome-Derived miRNA-185-5p Inhibitor via Liposomes Alleviates Apoptosis and Cuproptosis in Dilated Cardiomyopathy. International Journal of Nanomedicine. 2025; 20: 9407\u20139425.","DOI":"10.2147\/IJN.S522157"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Zolk O, Frohme M, Maurer A, Kluxen FW, Hentsch B, Zubakov D, et al. Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochemical and Biophysical Research Communications. 2002; 293: 1377\u20131382.","DOI":"10.1016\/S0006-291X(02)00387-X"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Moulik M, Vatta M, Witt SH, Arola AM, Murphy RT, McKenna WJ, et al. ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene. Journal of the American College of Cardiology. 2009; 54: 325\u2013333.","DOI":"10.1016\/j.jacc.2009.02.076"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Arimura T, Hayashi T, Matsumoto Y, Shibata H, Hiroi S, Nakamura T, et al. Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy. Biochemical and Biophysical Research Communications. 2007; 357: 162\u2013167.","DOI":"10.1016\/j.bbrc.2007.03.128"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Duboscq-Bidot L, Charron P, Ruppert V, Fauchier L, Richter A, Tavazzi L, et al. Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. European Heart Journal. 2009; 30: 2128\u20132136.","DOI":"10.1093\/eurheartj\/ehp225"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Arimura T, Bos JM, Sato A, Kubo T, Okamoto H, Nishi H, et al. Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 2009; 54: 334\u2013342.","DOI":"10.1016\/j.jacc.2008.12.082"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Crocini C, Arimura T, Reischmann S, Eder A, Braren I, Hansen A, et al. Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue. Basic Research in Cardiology. 2013; 108: 349.","DOI":"10.1007\/s00395-013-0349-x"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Cinquetti R, Badi I, Campione M, Bortoletto E, Chiesa G, Parolini C, et al. Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return. Human Mutation. 2008; 29: 468\u2013474.","DOI":"10.1002\/humu.20711"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Yang Y, Xia Y, Wu Y, Huang S, Teng Y, Liu X, et al. Ankyrin repeat domain 1: A novel gene for cardiac septal defects. The Journal of Gene Medicine. 2019; 21: e3070.","DOI":"10.1002\/jgm.3070"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Bogomolovas J, Brohm K, \u010celutkien\u0117 J, Bal\u010di\u016bnait\u0117 G, Bironait\u0117 D, Bukelskien\u0117 V, et al. Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression. BioMed Research International. 2015; 2015: 273936.","DOI":"10.1155\/2015\/273936"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Alfarano M, Ciccarelli F, Marchionni G, Ballatore F, Costantino J, Lattanzio A, et al. Hypertrophic Cardiomyopathy and Phenocopies: New Therapies for Old Diseases-Current Evidence and Future Perspectives. Journal of Clinical Medicine. 2025; 14: 4228.","DOI":"10.3390\/jcm14124228"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Bang ML, Gu Y, Dalton ND, Peterson KL, Chien KR, Chen J. The muscle ankyrin repeat proteins CARP, Ankrd2, and DARP are not essential for normal cardiac development and function at basal conditions and in response to pressure overload. PloS One. 2014; 9: e93638.","DOI":"10.1371\/journal.pone.0093638"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Kalyanaraman B. Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree? Redox Biology. 2020; 29: 101394.","DOI":"10.1016\/j.redox.2019.101394"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. The New England Journal of Medicine. 1998; 339: 900\u2013905.","DOI":"10.1056\/NEJM199809243391307"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Oka T, Maillet M, Watt AJ, Schwartz RJ, Aronow BJ, Duncan SA, et al. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circulation Research. 2006; 98: 837\u2013845.","DOI":"10.1161\/01.RES.0000215985.18538.c4"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Aries A, Paradis P, Lefebvre C, Schwartz RJ, Nemer M. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101: 6975\u20136980.","DOI":"10.1073\/pnas.0401833101"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Kim Y, Ma AG, Kitta K, Fitch SN, Ikeda T, Ihara Y, et al. Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis. Molecular Pharmacology. 2003; 63: 368\u2013377.","DOI":"10.1124\/mol.63.2.368"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Wolf D, Ley K. Immunity and Inflammation in Atherosclerosis. Circulation Research. 2019; 124: 315\u2013327.","DOI":"10.1161\/CIRCRESAHA.118.313591"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Wang C, Li Z, Liu Y, Yuan L. Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets. Theranostics. 2021; 11: 3996\u20134010.","DOI":"10.7150\/thno.56035"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"de Waard V, van Achterberg TAE, Beauchamp NJ, Pannekoek H, de Vries CJM. Cardiac ankyrin repeat protein (CARP) expression in human and murine atherosclerotic lesions: activin induces CARP in smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 2003; 23: 64\u201368.","DOI":"10.1161\/01.atv.0000042218.13101.50"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Frangogiannis NG. Pathophysiology of Myocardial Infarction. Comprehensive Physiology. 2015; 5: 1841\u20131875.","DOI":"10.1002\/cphy.c150006"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Cai C, Guo Z, Chang X, Li Z, Wu F, He J, et al. Empagliflozin attenuates cardiac microvascular ischemia\/reperfusion through activating the AMPK\u03b11\/ULK1\/FUNDC1\/mitophagy pathway. Redox Biology. 2022; 52: 102288.","DOI":"10.1016\/j.redox.2022.102288"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proceedings of the National Academy of Sciences of the United States of America. 1987; 84: 1404\u20131407.","DOI":"10.1073\/pnas.84.5.1404"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Miyamae M, Camacho SA, Weiner MW, Figueredo VM. Attenuation of postischemic reperfusion injury is related to prevention of [Ca2+] m overload in rat hearts. American Journal of Physiology-Heart and Circulatory Physiology. 1996; 271: H2145\u2013H2453.","DOI":"10.1152\/ajpheart.1996.271.5.H2145"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Lemasters JJ, Bond JM, Chacon E, Harper IS, Kaplan SH, Ohata H, et al. The pH paradox in ischemia-reperfusion injury to cardiac myocytes. EXS. 1996; 76: 99\u2013114.","DOI":"10.1007\/978-3-0348-8988-9_7"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovascular Research. 2004; 61: 481\u2013497.","DOI":"10.1016\/j.cardiores.2003.10.011"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Hausenloy DJ, Botker HE, Engstrom T, Erlinge D, Heusch G, Ibanez B, et al. Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. European Heart Journal. 2017; 38: 935\u2013941.","DOI":"10.1093\/eurheartj\/ehw145"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Cao Z, Umek RM, McKnight SL. Regulated expression of three C\/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes & Development. 1991; 5: 1538\u20131552.","DOI":"10.1101\/gad.5.9.1538"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Oyadomari S, Mori M. Roles of CHOP\/GADD153 in endoplasmic reticulum stress. Cell Death and Differentiation. 2004; 11: 381\u2013389.","DOI":"10.1038\/sj.cdd.4401373"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Han XJ, Chae JK, Lee MJ, You KR, Lee BH, Kim DG. Involvement of GADD153 and cardiac ankyrin repeat protein in hypoxia-induced apoptosis of H9c2 cells. The Journal of Biological Chemistry. 2005; 280: 23122\u201323129.","DOI":"10.1074\/jbc.M501095200"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Lee MJ, Kwak YK, You KR, Lee BH, Kim DG. Involvement of GADD153 and cardiac ankyrin repeat protein in cardiac ischemia-reperfusion injury. Experimental & Molecular Medicine. 2009; 41: 243\u2013252.","DOI":"10.3858\/emm.2009.41.4.027"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Xu Z, Lu D, Yuan J, Wang L, Wang J, Lei Z, et al. Storax Attenuates Cardiac Fibrosis following Acute Myocardial Infarction in Rats via Suppression of AT1R-Ankrd1-P53 Signaling Pathway. International Journal of Molecular Sciences. 2022; 23: 13161.","DOI":"10.3390\/ijms232113161"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Liu L, Jiang Q, Du C, Yang T, Zhou L, Chen J, et al. Ankrd1 regulates endogenous cardiac regeneration in mice by modulating cyclin D1. European Journal of Pharmacology. 2024; 983: 177005.","DOI":"10.1016\/j.ejphar.2024.177005"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Cabral GHB, Guerra JVN, Pedrosa KU, Conrado PLM, Fonseca JHDA, Luna VLM, et al. Congenital heart disease: epidemiological profile of live births, geographical distribution and temporal trends in Brazil from 2012 to 2022. BMC Cardiovascular Disorders. 2025; 25: 599.","DOI":"10.1186\/s12872-025-05079-8"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Correa-Villase\u00f1or A, Ferencz C, Boughman JA, Neill CA. Total anomalous pulmonary venous return: familial and environmental factors. The Baltimore-Washington Infant Study Group. Teratology. 1991; 44: 415\u2013428.","DOI":"10.1002\/tera.1420440408"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Piroddi N, Pesce P, Scellini B, Manzini S, Ganzetti GS, Badi I, et al. Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction. Cardiovascular Research. 2020; 116: 1458\u20131472.","DOI":"10.1093\/cvr\/cvz291"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Kamel R, Leroy J, Vandecasteele G, Fischmeister R. Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure. Nature Reviews. Cardiology. 2023; 20: 90\u2013108.","DOI":"10.1038\/s41569-022-00756-z"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Vaduganathan M, Claggett BL, Jhund PS, Cunningham JW, Pedro Ferreira J, Zannad F, et al. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials. Lancet (London, England). 2020; 396: 121\u2013128.","DOI":"10.1016\/S0140-6736(20)30748-0"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Wei YJ, Cui CJ, Huang YX, Zhang XL, Zhang H, Hu SS. Upregulated expression of cardiac ankyrin repeat protein in human failing hearts due to arrhythmogenic right ventricular cardiomyopathy. European Journal of Heart Failure. 2009; 11: 559\u2013566.","DOI":"10.1093\/eurjhf\/hfp049"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Shen L, Chen C, Wei X, Li X, Luo G, Zhang J, et al. Overexpression of ankyrin repeat domain 1 enhances cardiomyocyte apoptosis by promoting p53 activation and mitochondrial dysfunction in rodents. Clinical Science (London, England : 1979). 2015; 128: 665\u2013678.","DOI":"10.1042\/CS20140586"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Kempton A, Cefalu M, Justice C, Baich T, Derbala M, Canan B, et al. Altered regulation of cardiac ankyrin repeat protein in heart failure. Heliyon. 2018; 4: e00514.","DOI":"10.1016\/j.heliyon.2018.e00514"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Torrado M, Nespereira B, Bouzamayor Y, Centeno A, L\u00f3pez E, Mikhailov AT. Differential atrial versus ventricular ANKRD1 gene expression is oppositely regulated at diastolic heart failure. FEBS Letters. 2006; 580: 4182\u20134187.","DOI":"10.1016\/j.febslet.2006.06.073"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Zolk O, Marx M, J\u00e4ckel E, El-Armouche A, Eschenhagen T. Beta-adrenergic stimulation induces cardiac ankyrin repeat protein expression: involvement of protein kinase A and calmodulin-dependent kinase. Cardiovascular Research. 2003; 59: 563\u2013572.","DOI":"10.1016\/s0008-6363(03)00476-0"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/7\/10.31083\/RCM48749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:32:45Z","timestamp":1785407565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/7\/10.31083\/RCM48749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":90,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1530-6550(26)02324-0"],"URL":"https:\/\/doi.org\/10.31083\/rcm48749","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"article-number":"48749"}}